Calidi Biotherapeutics CLDI
NYSE CLDI
$1.07 +0.01 (+0.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

Calidi Biotherapeutics (CLDI) Income from Non-Controlling Interests (2024 - 2025)

Updated

Calidi Biotherapeutics (CLDI) reported Income from Non-Controlling Interests of -$3,000 for Q4 2025, compared with -$51,000 a year earlier.

Analysis

Calidi Biotherapeutics (CLDI) Income from Non-Controlling Interests (2024 - 2025) Analysis & Trends

For FY2025, Calidi Biotherapeutics posted Income from Non-Controlling Interests of -$157,000.

  • By year, Income from Non-Controlling Interests came in at -$66,000 in FY2024.
  • Per Business Quant data, the three quarters before Q4 2025 came in at -$32,000 (Q3 2025), -$46,000 (Q2 2025) and -$76,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -2.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -7.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 10.00 Mn
10 Calidi Biotherapeutics 1.52 Mn -23.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -3,000.00
Sep 30, 2025 -32,000.00
Jun 30, 2025 -46,000.00
Mar 31, 2025 -76,000.00
Dec 31, 2024 -51,000.00
Sep 30, 2024 -15,000.00
API Access

Calidi Biotherapeutics Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=CLDI&period=max&api_key=YOUR_API_KEY